In December of 2021, the DEA briefly place various nitazenes on its Schedule I [9]. Because there are actually couple of validated strategies to find these substances and little is known with regards to the network of clandestine labs and chemists who manufacture these medicines, the geographical distribution of such medicine is not really recogniz